Clinical Trial Update: Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring oral vinorelbine plus capecitabine in advanced HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• oral vinorelbine (vinorelbine)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN